Case Report: Failure of eculizumab to block complement to prevent relapse of anti-phospholipid syndrome in kidney transplant recipient.
Saved in:
| Title: | Case Report: Failure of eculizumab to block complement to prevent relapse of anti-phospholipid syndrome in kidney transplant recipient. |
|---|---|
| Authors: | Laban T; Assistance Publique Hôpitaux de Paris (AP-HP), Groupe Hospitalo-Universitaire Chenevier Mondor, Nephrology and Renal Transplantation Department, Fédération Hospitalo-Universitaire 'Innovative Therapy for Immune Disorders,', Créteil, France., Pigneur F; Assistance Publique Hôpitaux de Paris (AP-HP), Groupe hospitalo-universitaire Chenevier Mondor, Radiology Department, Créteil, France., Guillaud C; Assistance Publique Hôpitaux de Paris (AP-HP), Groupe Hospitalo-Universitaire Chenevier Mondor, Internal Medicine Department, Fédération Hospitalo-Universitaire 'Innovative Therapy for Immune Disorders,', Créteil, France., Dragon Durey MA; Université Paris Cité, INSERM UMRS 1138, Centre de Recherche des Cordeliers, Assistance Publique Hôpitaux de Paris (AP-HPP), Groupe Hospitalier Paris Centre, Hôpital Européen Georges Pompidou, Paris, France.; Assistance Publique Hôpitaux de Paris (AP-HP), Groupe Hospitalier Paris Centre, Hôpital Européen Georges Pompidou, Paris, France., Hamidi H; Université Paris Cité, INSERM UMRS 1138, Centre de Recherche des Cordeliers, Assistance Publique Hôpitaux de Paris (AP-HPP), Groupe Hospitalier Paris Centre, Hôpital Européen Georges Pompidou, Paris, France., Pilon C; Univ Paris Est Creteil, INSERM IMRB U955, Créteil, France.; Assistance Publique Hôpitaux de Paris (AP-HP), Groupe Hospitalo-Universitaire Chenevier Mondor, Centre d'Investigation Clinique Biotherapy, Fédération Hospitalo-Universitaire 'Innovative Therapy for Immune Disorders,', Créteil, France., Michel M; Assistance Publique Hôpitaux de Paris (AP-HP), Groupe Hospitalo-Universitaire Chenevier Mondor, Internal Medicine Department, Fédération Hospitalo-Universitaire 'Innovative Therapy for Immune Disorders,', Créteil, France., Joher N; Assistance Publique Hôpitaux de Paris (AP-HP), Groupe Hospitalo-Universitaire Chenevier Mondor, Nephrology and Renal Transplantation Department, Fédération Hospitalo-Universitaire 'Innovative Therapy for Immune Disorders,', Créteil, France., Grimbert P; Assistance Publique Hôpitaux de Paris (AP-HP), Groupe Hospitalo-Universitaire Chenevier Mondor, Nephrology and Renal Transplantation Department, Fédération Hospitalo-Universitaire 'Innovative Therapy for Immune Disorders,', Créteil, France.; Univ Paris Est Creteil, INSERM IMRB U955, Créteil, France.; Assistance Publique Hôpitaux de Paris (AP-HP), Groupe Hospitalo-Universitaire Chenevier Mondor, Centre d'Investigation Clinique Biotherapy, Fédération Hospitalo-Universitaire 'Innovative Therapy for Immune Disorders,', Créteil, France., Sakhi H; Assistance Publique Hôpitaux de Paris (AP-HP), Groupe Hospitalo-Universitaire Chenevier Mondor, Nephrology and Renal Transplantation Department, Fédération Hospitalo-Universitaire 'Innovative Therapy for Immune Disorders,', Créteil, France.; Assistance Publique Hôpitaux de Paris (AP-HP), Groupe Hospitalo-Universitaire Chenevier Mondor, Internal Medicine Department, Fédération Hospitalo-Universitaire 'Innovative Therapy for Immune Disorders,', Créteil, France., Morel A; Assistance Publique Hôpitaux de Paris (AP-HP), Groupe Hospitalo-Universitaire Chenevier Mondor, Nephrology and Renal Transplantation Department, Fédération Hospitalo-Universitaire 'Innovative Therapy for Immune Disorders,', Créteil, France., Matignon M; Assistance Publique Hôpitaux de Paris (AP-HP), Groupe Hospitalo-Universitaire Chenevier Mondor, Nephrology and Renal Transplantation Department, Fédération Hospitalo-Universitaire 'Innovative Therapy for Immune Disorders,', Créteil, France.; Univ Paris Est Creteil, INSERM IMRB U955, Créteil, France.; Assistance Publique Hôpitaux de Paris (AP-HP), Groupe Hospitalo-Universitaire Chenevier Mondor, Centre d'Investigation Clinique Biotherapy, Fédération Hospitalo-Universitaire 'Innovative Therapy for Immune Disorders,', Créteil, France. |
| Source: | Frontiers in nephrology [Front Nephrol] 2025 Jun 18; Vol. 5, pp. 1572641. Date of Electronic Publication: 2025 Jun 18 (Print Publication: 2025). |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 9918469487906676 Publication Model: eCollection Cited Medium: Internet ISSN: 2813-0626 (Electronic) Linking ISSN: 28130626 NLM ISO Abbreviation: Front Nephrol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40606218 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Case Report: Failure of eculizumab to block complement to prevent relapse of anti-phospholipid syndrome in kidney transplant recipient. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Laban+T%22">Laban T</searchLink>; Assistance Publique Hôpitaux de Paris (AP-HP), Groupe Hospitalo-Universitaire Chenevier Mondor, Nephrology and Renal Transplantation Department, Fédération Hospitalo-Universitaire 'Innovative Therapy for Immune Disorders,', Créteil, France.<br /><searchLink fieldCode="AU" term="%22Pigneur+F%22">Pigneur F</searchLink>; Assistance Publique Hôpitaux de Paris (AP-HP), Groupe hospitalo-universitaire Chenevier Mondor, Radiology Department, Créteil, France.<br /><searchLink fieldCode="AU" term="%22Guillaud+C%22">Guillaud C</searchLink>; Assistance Publique Hôpitaux de Paris (AP-HP), Groupe Hospitalo-Universitaire Chenevier Mondor, Internal Medicine Department, Fédération Hospitalo-Universitaire 'Innovative Therapy for Immune Disorders,', Créteil, France.<br /><searchLink fieldCode="AU" term="%22Dragon+Durey+MA%22">Dragon Durey MA</searchLink>; Université Paris Cité, INSERM UMRS 1138, Centre de Recherche des Cordeliers, Assistance Publique Hôpitaux de Paris (AP-HPP), Groupe Hospitalier Paris Centre, Hôpital Européen Georges Pompidou, Paris, France.; Assistance Publique Hôpitaux de Paris (AP-HP), Groupe Hospitalier Paris Centre, Hôpital Européen Georges Pompidou, Paris, France.<br /><searchLink fieldCode="AU" term="%22Hamidi+H%22">Hamidi H</searchLink>; Université Paris Cité, INSERM UMRS 1138, Centre de Recherche des Cordeliers, Assistance Publique Hôpitaux de Paris (AP-HPP), Groupe Hospitalier Paris Centre, Hôpital Européen Georges Pompidou, Paris, France.<br /><searchLink fieldCode="AU" term="%22Pilon+C%22">Pilon C</searchLink>; Univ Paris Est Creteil, INSERM IMRB U955, Créteil, France.; Assistance Publique Hôpitaux de Paris (AP-HP), Groupe Hospitalo-Universitaire Chenevier Mondor, Centre d'Investigation Clinique Biotherapy, Fédération Hospitalo-Universitaire 'Innovative Therapy for Immune Disorders,', Créteil, France.<br /><searchLink fieldCode="AU" term="%22Michel+M%22">Michel M</searchLink>; Assistance Publique Hôpitaux de Paris (AP-HP), Groupe Hospitalo-Universitaire Chenevier Mondor, Internal Medicine Department, Fédération Hospitalo-Universitaire 'Innovative Therapy for Immune Disorders,', Créteil, France.<br /><searchLink fieldCode="AU" term="%22Joher+N%22">Joher N</searchLink>; Assistance Publique Hôpitaux de Paris (AP-HP), Groupe Hospitalo-Universitaire Chenevier Mondor, Nephrology and Renal Transplantation Department, Fédération Hospitalo-Universitaire 'Innovative Therapy for Immune Disorders,', Créteil, France.<br /><searchLink fieldCode="AU" term="%22Grimbert+P%22">Grimbert P</searchLink>; Assistance Publique Hôpitaux de Paris (AP-HP), Groupe Hospitalo-Universitaire Chenevier Mondor, Nephrology and Renal Transplantation Department, Fédération Hospitalo-Universitaire 'Innovative Therapy for Immune Disorders,', Créteil, France.; Univ Paris Est Creteil, INSERM IMRB U955, Créteil, France.; Assistance Publique Hôpitaux de Paris (AP-HP), Groupe Hospitalo-Universitaire Chenevier Mondor, Centre d'Investigation Clinique Biotherapy, Fédération Hospitalo-Universitaire 'Innovative Therapy for Immune Disorders,', Créteil, France.<br /><searchLink fieldCode="AU" term="%22Sakhi+H%22">Sakhi H</searchLink>; Assistance Publique Hôpitaux de Paris (AP-HP), Groupe Hospitalo-Universitaire Chenevier Mondor, Nephrology and Renal Transplantation Department, Fédération Hospitalo-Universitaire 'Innovative Therapy for Immune Disorders,', Créteil, France.; Assistance Publique Hôpitaux de Paris (AP-HP), Groupe Hospitalo-Universitaire Chenevier Mondor, Internal Medicine Department, Fédération Hospitalo-Universitaire 'Innovative Therapy for Immune Disorders,', Créteil, France.<br /><searchLink fieldCode="AU" term="%22Morel+A%22">Morel A</searchLink>; Assistance Publique Hôpitaux de Paris (AP-HP), Groupe Hospitalo-Universitaire Chenevier Mondor, Nephrology and Renal Transplantation Department, Fédération Hospitalo-Universitaire 'Innovative Therapy for Immune Disorders,', Créteil, France.<br /><searchLink fieldCode="AU" term="%22Matignon+M%22">Matignon M</searchLink>; Assistance Publique Hôpitaux de Paris (AP-HP), Groupe Hospitalo-Universitaire Chenevier Mondor, Nephrology and Renal Transplantation Department, Fédération Hospitalo-Universitaire 'Innovative Therapy for Immune Disorders,', Créteil, France.; Univ Paris Est Creteil, INSERM IMRB U955, Créteil, France.; Assistance Publique Hôpitaux de Paris (AP-HP), Groupe Hospitalo-Universitaire Chenevier Mondor, Centre d'Investigation Clinique Biotherapy, Fédération Hospitalo-Universitaire 'Innovative Therapy for Immune Disorders,', Créteil, France. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229918469487906676%22">Frontiers in nephrology</searchLink> [Front Nephrol] 2025 Jun 18; Vol. 5, pp. 1572641. <i>Date of Electronic Publication: </i>2025 Jun 18 (<i>Print Publication: </i>2025). – Name: TypePub Label: Publication Type Group: TypPub Data: Case Reports; Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media+S%2EA%22">Frontiers Media S.A </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>9918469487906676 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2813-0626 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2228130626%22">28130626 </searchLink><i>NLM ISO Abbreviation: </i>Front Nephrol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40606218 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fneph.2025.1572641 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1572641 Titles: – TitleFull: Case Report: Failure of eculizumab to block complement to prevent relapse of anti-phospholipid syndrome in kidney transplant recipient. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Laban T – PersonEntity: Name: NameFull: Pigneur F – PersonEntity: Name: NameFull: Guillaud C – PersonEntity: Name: NameFull: Dragon Durey MA – PersonEntity: Name: NameFull: Hamidi H – PersonEntity: Name: NameFull: Pilon C – PersonEntity: Name: NameFull: Michel M – PersonEntity: Name: NameFull: Joher N – PersonEntity: Name: NameFull: Grimbert P – PersonEntity: Name: NameFull: Sakhi H – PersonEntity: Name: NameFull: Morel A – PersonEntity: Name: NameFull: Matignon M IsPartOfRelationships: – BibEntity: Dates: – D: 18 M: 06 Text: 2025 Jun 18 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2813-0626 Numbering: – Type: volume Value: 5 Titles: – TitleFull: Frontiers in nephrology Type: main |
| ResultId | 1 |